本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Inhibrx Biosciences

95.01
+2.252.43%
盤後:95.010.00000.00%19:30 EDT
成交量:8.68萬
成交額:822.67萬
市值:13.94億
市盈率:-10.70
高:95.81
開:92.70
低:92.70
收:92.76
52周最高:155.29
52周最低:28.16
股本:1,467.12萬
流通股本:858.89萬
量比:0.43
換手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):-8.8768
每股收益(LYR):-9.0434
淨資產收益率:-1773.60%
總資產收益率:-43.61%
市淨率:-26.31
市盈率(LYR):-10.51

資料載入中...

2026/09/28

重要事件披露

Form 8-K - Current report
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/08

重要事件披露

Form 8-K - Current report
2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/16

重要事件披露

Form 8-K - Current report
2026/06/15

重要事件披露

Form 8-K - Current report
2026/06/03

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report